José Thomas

Prognostic Value of Positron Emission Tomography (PET) With Fluorine-18 Fluorodeoxyglucose ([¹⁸F]FDG) After First-Line Chemotherapy in Non-Hodgkin’s Lymphoma: Is [¹⁸F]FDG-PET a Valid Alternative to Conventional Diagnostic Methods?

Karoline Spaepen, Sigrid Stroobants, Patrick Dupont et al. · Journal of Clinical Oncology · 2001 · 466 citations

Medicine, Nuclear Medicine, Oncology +17

Chemotherapy plus Involved-Field Radiation in Early-Stage Hodgkin's Disease

Christophe Fermé, Houchingue Eghbali, J.H. Meerwaldt et al. · New England Journal of Medicine · 2007 · 446 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin’s lymphoma

Karoline Spaepen, Sigrid Stroobants, Patrick Dupont et al. · Annals of Oncology · 2002 · 409 citations · Full text

Medicine, Nuclear Medicine, Oncology +13

High-Dose Methotrexate-Based Chemotherapy Followed by Consolidating Radiotherapy in Non–AIDS-Related Primary Central Nervous System Lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962

Philip Poortmans, Hanneke C. Kluin‐Nelemans, Hanny Haaxma-Reiche et al. · Journal of Clinical Oncology · 2003 · 333 citations

Medicine, Oncology, Pharmacotherapy +15

Involved-Field Radiotherapy for Advanced Hodgkin's Lymphoma

Berthe M.P. Aleman, John Raemaekers, Umberto Tirelli et al. · New England Journal of Medicine · 2003 · 307 citations · Full text

Medicine, Oncology, Radiation Oncology +11